| 000 | 01753 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515165555.0 | ||
| 264 | 0 | _c20090506 | |
| 008 | 200905s 0 0 rus d | ||
| 022 | _a0132-3423 | ||
| 024 | 7 |
_a10.1134/s1068162009010105 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKomissarov, V V | |
| 245 | 0 | 0 |
_a[Polymethylene derivatives of nucleic bases with omega-functional groups: VII. Cytotoxicity in the series of N-(2-oxocyclohexyl)-omega-oxoalkyl substituted purines and pyrimidines]. _h[electronic resource] |
| 260 |
_bBioorganicheskaia khimiia _c |
||
| 300 |
_a84-94 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlkylation |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCytosine _xpharmacology |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxanthine _xpharmacology |
| 650 | 0 | 4 |
_aPurines _xchemistry |
| 650 | 0 | 4 |
_aPyrimidines _xchemistry |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aThymine _xpharmacology |
| 650 | 0 | 4 |
_aUracil _xpharmacology |
| 700 | 1 | _aVolgareva, G M | |
| 700 | 1 | _aOl'shanskaia, Ia S | |
| 700 | 1 | _aChernyshova, M E | |
| 700 | 1 | _aZavalishina, L E | |
| 700 | 1 | _aFrank, G A | |
| 700 | 1 | _aShtil', A A | |
| 700 | 1 | _aKritsyn, A M | |
| 773 | 0 |
_tBioorganicheskaia khimiia _gvol. 35 _gno. 1 _gp. 84-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1134/s1068162009010105 _zAvailable from publisher's website |
| 999 |
_c18808967 _d18808967 |
||